Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose crossover comparison of levocetirizine, desloratadine, rupatadine, ebastine, and placebo in seasonal allergic rhinitis
2005-004752-13Phase 4Active
- Sponsor
- Hospital Universitari Germans Trias i Pujol
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of levocetirizine, desloratadine, rupatadine and eribulin in seasonal allergic rhinitis (SAR) (5 arms), sponsored by Hospital Universitari Germans Trias i Pujol. Primary endpoint: Suppression of histamine-induced wheal and flare skin response. Started Mar 2006; status: active.
02
Drugs
levocetirizinedesloratadinerupatadineeribulin
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on 2005-004752-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004752-13.